These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 27573064)
1. Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules. Francisco AP; Paulo A Curr Med Chem; 2017; 24(42):4873-4904. PubMed ID: 27573064 [TBL] [Abstract][Full Text] [Related]
2. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes. Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159 [TBL] [Abstract][Full Text] [Related]
3. Recent Update on Targeting Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454 [TBL] [Abstract][Full Text] [Related]
4. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile. Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395 [TBL] [Abstract][Full Text] [Related]
5. Human MYC G-quadruplex: From discovery to a cancer therapeutic target. Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579 [TBL] [Abstract][Full Text] [Related]
6. Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures? Amato J; Pagano A; Cosconati S; Amendola G; Fotticchia I; Iaccarino N; Marinello J; De Magis A; Capranico G; Novellino E; Pagano B; Randazzo A Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1271-1280. PubMed ID: 27836755 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies. Islam MK; Jackson PJ; Rahman KM; Thurston DE Future Med Chem; 2016 Jul; 8(11):1259-90. PubMed ID: 27442231 [TBL] [Abstract][Full Text] [Related]
8. G-quadruplex structures and their interaction diversity with ligands. Zhang S; Wu Y; Zhang W ChemMedChem; 2014 May; 9(5):899-911. PubMed ID: 24729465 [TBL] [Abstract][Full Text] [Related]
9. A two-pronged attack on DNA: targeting guanine quadruplexes with nonplanar porphyrins and DNA-binding small molecules. Rozas I; Senge MO Future Med Chem; 2016 Apr; 8(6):609-12. PubMed ID: 27057958 [No Abstract] [Full Text] [Related]
10. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961 [TBL] [Abstract][Full Text] [Related]
11. Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models. Zorzan E; Da Ros S; Musetti C; Shahidian LZ; Coelho NF; Bonsembiante F; Létard S; Gelain ME; Palumbo M; Dubreuil P; Giantin M; Sissi C; Dacasto M Oncotarget; 2016 Apr; 7(16):21658-75. PubMed ID: 26942875 [TBL] [Abstract][Full Text] [Related]
12. Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazole‒carbazole ligands. Kaulage MH; Maji B; Pasadi S; Ali A; Bhattacharya S; Muniyappa K Eur J Med Chem; 2018 Mar; 148():178-194. PubMed ID: 29459277 [TBL] [Abstract][Full Text] [Related]
13. G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy. Awadasseid A; Ma X; Wu Y; Zhang W Biomed Pharmacother; 2021 Jul; 139():111550. PubMed ID: 33831835 [TBL] [Abstract][Full Text] [Related]
14. Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme. Elango H; Das RN; Saha A Future Med Chem; 2024; 16(19):2043-2067. PubMed ID: 39316718 [TBL] [Abstract][Full Text] [Related]
15. Energetics of ligand binding to G-quadruplexes. Giancola C; Pagano B Top Curr Chem; 2013; 330():211-42. PubMed ID: 22851158 [TBL] [Abstract][Full Text] [Related]
17. Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives. Catalano R; Moraca F; Amato J; Cristofari C; Rigo R; Via LD; Rocca R; Lupia A; Maruca A; Costa G; Catalanotti B; Artese A; Pagano B; Randazzo A; Sissi C; Novellino E; Alcaro S Eur J Med Chem; 2019 Nov; 182():111627. PubMed ID: 31446246 [TBL] [Abstract][Full Text] [Related]
18. Gaining insights into the small molecule targeting of the G-quadruplex in the c-MYC promoter using NMR and an allele-specific transcriptional assay. Kaiser CE; Gokhale V; Yang D; Hurley LH Top Curr Chem; 2013; 330():1-21. PubMed ID: 22752577 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains. Lavrado J; Borralho PM; Ohnmacht SA; Castro RE; Rodrigues CM; Moreira R; dos Santos DJ; Neidle S; Paulo A ChemMedChem; 2013 Oct; 8(10):1648-61. PubMed ID: 23960016 [TBL] [Abstract][Full Text] [Related]
20. [Research progress in targeting DNA G-quadruplexes using natural products]. Chen ZY; Cheng RS; Ayixia W; Liu YS; Wang KB Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3421-3431. PubMed ID: 39041114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]